Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chondroma × regorafenib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 95 Carcinoma, Hepatocellular 25 Neoplasm Metastasis 18 Neoplasms 15 Gastrointestinal Stromal Tumors 12 Rectal Neoplasms 10 Colonic Neoplasms 10 Glioblastoma 7 Liver Neoplasms 6 Stomach Neoplasms 5 Sarcoma 5 Ovarian Neoplasms 5 Melanoma 5 Sarcoma, Ewing 4 Osteosarcoma 4 Esophageal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma 4 Small Cell Lung Carcinoma 3 Rhabdomyosarcoma 3 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Colorectal Cancer Metastatic 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Carcinoma 3 Advanced Colorectal Cancer 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2

Interventions

regorafenib 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02389244 2025-09-16

REGOBONE

UNICANCER

Phase 2 Active not recruiting

Chondroma, Chondrosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡